6CVO image
Entry Detail
PDB ID:
6CVO
Title:
Human Aprataxin (Aptx) bound to nicked RNA-DNA, AMP and Zn product complex
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2018-03-28
Release Date:
2018-08-29
Method Details:
Experimental Method:
Resolution:
2.40 Å
R-Value Free:
0.22
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Aprataxin
Chain IDs:A, C (auth: B)
Chain Length:182
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polydeoxyribonucleotide/polyribonucleotide hybrid
Description:DNA/RNA (5'-R(P*G)-D(P*TP*TP*CP*TP*AP*TP*AP*TP*AP*TP*AP*GP*AP*AP*CP*GP*CP*TP*GP*TP*T)-3')
Chain IDs:B (auth: D), D (auth: G)
Chain Length:22
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polydeoxyribonucleotide
Description:DNA (5'-D(*AP*AP*CP*AP*GP*C)-3')
Chain IDs:E, F (auth: H)
Chain Length:6
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Mechanism of APTX nicked DNA sensing and pleiotropic inactivation in neurodegenerative disease.
EMBO J. 37 ? ? (2018)
PMID: 29934293 DOI: 10.15252/embj.201798875

Abstact

The failure of DNA ligases to complete their catalytic reactions generates cytotoxic adenylated DNA strand breaks. The APTX RNA-DNA deadenylase protects genome integrity and corrects abortive DNA ligation arising during ribonucleotide excision repair and base excision DNA repair, and APTX human mutations cause the neurodegenerative disorder ataxia with oculomotor ataxia 1 (AOA1). How APTX senses cognate DNA nicks and is inactivated in AOA1 remains incompletely defined. Here, we report X-ray structures of APTX engaging nicked RNA-DNA substrates that provide direct evidence for a wedge-pivot-cut strategy for 5'-AMP resolution shared with the alternate 5'-AMP processing enzymes POLβ and FEN1. Our results uncover a DNA-induced fit mechanism regulating APTX active site loop conformations and assembly of a catalytically competent active center. Further, based on comprehensive biochemical, X-ray and solution NMR results, we define a complex hierarchy for the differential impacts of the AOA1 mutational spectrum on APTX structure and activity. Sixteen AOA1 variants impact APTX protein stability, one mutation directly alters deadenylation reaction chemistry, and a dominant AOA1 variant unexpectedly allosterically modulates APTX active site conformations.

Legend

Protein

Chemical

Disease

Primary Citation of related structures